Champions Oncology Files 8-K on Financials
Ticker: CSBR · Form: 8-K · Filed: Dec 11, 2024 · CIK: 771856
| Field | Detail |
|---|---|
| Company | Champions Oncology, INC. (CSBR) |
| Form Type | 8-K |
| Filed Date | Dec 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k, company-history
TL;DR
Champions Oncology dropped an 8-K on 12/11 detailing financials. Check it out.
AI Summary
On December 11, 2024, Champions Oncology, Inc. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the report being filed as of December 11, 2024. The company, previously known as Champions Biotechnology, Inc., is incorporated in Delaware and has its principal business address in Baltimore, MD.
Why It Matters
This 8-K filing provides crucial updates on Champions Oncology's financial performance and operational status, which is essential for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or high-risk events.
Key Numbers
- 001-11504 — Commission File Number (Identifies the company's SEC filing history.)
- 52-1401755 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CHAMPIONS ONCOLOGY, INC. (company) — Registrant
- CHAMPIONS BIOTECHNOLOGY, INC. (company) — Former Company Name
- CHAMPIONS SPORTS INC (company) — Former Company Name
- INTERNATIONAL GROUP INC (company) — Former Company Name
- December 11, 2024 (date) — Date of Report
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is as of December 11, 2024.
What is the company's primary business classification?
The company's Standard Industrial Classification is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
What is the company's fiscal year end?
The company's fiscal year ends on April 30 (0430).
What were the company's previous names?
The company was formerly known as Champions Biotechnology, Inc., Champions Sports Inc, and International Group Inc.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-12-11 16:40:18
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share CSBR The Nasdaq Stock Market
Filing Documents
- csbr-20241211.htm (8-K) — 34KB
- csbr8-k10312024ex991xq225.htm (EX-99.1) — 167KB
- logobranding_headerleftali.jpg (GRAPHIC) — 31KB
- 0001628280-24-050789.txt ( ) — 376KB
- csbr-20241211.xsd (EX-101.SCH) — 2KB
- csbr-20241211_def.xml (EX-101.DEF) — 3KB
- csbr-20241211_lab.xml (EX-101.LAB) — 21KB
- csbr-20241211_pre.xml (EX-101.PRE) — 12KB
- csbr-20241211_htm.xml (XML) — 2KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On December 11, 2024, Champions Oncology, Inc. (the "Company") issued a press release regarding the Company's unaudited financial results for its second quarter ended October 31, 2024. A copy of the Company's press release is attached hereto as Exhibit 99.1. The information contained under Item 2.02 in this Current Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is filed herewith: Exhibit No. 99.1 Press Release dated December 11, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CHAMPIONS ONCOLOGY, INC. (Registrant) Date: December 11, 2024 By: /s/ Ronnie Morris Ronnie Morris Chief Executive Officer